BR9606769A - Tablete e processos para tratamento de uma infecção de vírus do herpes em um humano e para preparação do tablete - Google Patents

Tablete e processos para tratamento de uma infecção de vírus do herpes em um humano e para preparação do tablete

Info

Publication number
BR9606769A
BR9606769A BR9606769A BR9606769A BR9606769A BR 9606769 A BR9606769 A BR 9606769A BR 9606769 A BR9606769 A BR 9606769A BR 9606769 A BR9606769 A BR 9606769A BR 9606769 A BR9606769 A BR 9606769A
Authority
BR
Brazil
Prior art keywords
tablet
treating
preparing
human
processes
Prior art date
Application number
BR9606769A
Other languages
English (en)
Portuguese (pt)
Inventor
Barry Howard Carter
Lloyd Gary Tillman
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10768317&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9606769(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of BR9606769A publication Critical patent/BR9606769A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BR9606769A 1995-01-20 1996-01-19 Tablete e processos para tratamento de uma infecção de vírus do herpes em um humano e para preparação do tablete BR9606769A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9501127.6A GB9501127D0 (en) 1995-01-20 1995-01-20 Tablet
PCT/GB1996/000111 WO1996022082A1 (en) 1995-01-20 1996-01-19 Valaciclovir tablets containing colloidal silicon dioxide

Publications (1)

Publication Number Publication Date
BR9606769A true BR9606769A (pt) 1997-12-30

Family

ID=10768317

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9606769A BR9606769A (pt) 1995-01-20 1996-01-19 Tablete e processos para tratamento de uma infecção de vírus do herpes em um humano e para preparação do tablete

Country Status (38)

Country Link
US (1) US5879706A (OSRAM)
EP (1) EP0806943B1 (OSRAM)
JP (1) JP3350055B2 (OSRAM)
KR (1) KR100412298B1 (OSRAM)
CN (2) CN1131026C (OSRAM)
AP (1) AP666A (OSRAM)
AT (1) ATE190483T1 (OSRAM)
AU (1) AU710823B2 (OSRAM)
BG (1) BG63187B1 (OSRAM)
BR (1) BR9606769A (OSRAM)
CA (1) CA2210891C (OSRAM)
CY (1) CY2182B1 (OSRAM)
CZ (1) CZ296514B6 (OSRAM)
DE (1) DE69607146T2 (OSRAM)
DK (1) DK0806943T3 (OSRAM)
EA (1) EA000276B1 (OSRAM)
EE (1) EE03336B1 (OSRAM)
ES (1) ES2145425T3 (OSRAM)
FI (1) FI119722B (OSRAM)
GB (1) GB9501127D0 (OSRAM)
GE (1) GEP20022752B (OSRAM)
GR (1) GR3033677T3 (OSRAM)
HU (1) HU226131B1 (OSRAM)
IL (1) IL116830A (OSRAM)
IN (1) IN181318B (OSRAM)
MY (1) MY126346A (OSRAM)
NO (1) NO311488B1 (OSRAM)
NZ (1) NZ298846A (OSRAM)
OA (1) OA10500A (OSRAM)
PL (1) PL185307B1 (OSRAM)
PT (1) PT806943E (OSRAM)
RO (1) RO118175B1 (OSRAM)
SK (1) SK282030B6 (OSRAM)
TR (1) TR199700657T1 (OSRAM)
UA (1) UA68325C2 (OSRAM)
UY (2) UY25774A1 (OSRAM)
WO (1) WO1996022082A1 (OSRAM)
ZA (1) ZA96448B (OSRAM)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
DK0874631T3 (da) * 1996-01-19 2004-03-22 Glaxo Group Ltd Anvendelse af valaciclovir til fremstilling af et medikament til behandling af genital herpes ved en enkelt daglig anvendelse
AR016827A1 (es) * 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
AR017512A1 (es) * 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
EP1140034B1 (en) * 1998-12-18 2003-11-26 Abbott Laboratories Controlled release formulation of divalproex sodium
GB0010446D0 (en) * 2000-04-28 2000-06-14 Glaxo Wellcome Kk Pharmaceutical formulation
HRP20030858A2 (en) * 2001-05-01 2005-08-31 Pfizer Products Inc. Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency
US7815936B2 (en) * 2001-10-30 2010-10-19 Evonik Degussa Gmbh Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
CA2465420A1 (en) * 2001-11-05 2003-05-15 Glaxo Group Limited Anhydrous crystal form of valaciclovir hydrochloride
US6849737B2 (en) * 2001-11-14 2005-02-01 Teva Pharmaceutical Industries Ltd. Synthesis and purification of valacyclovir
GB0203296D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
EP1517678A2 (en) * 2002-06-24 2005-03-30 Ranbaxy Laboratories Limited Process for the preparation of robust formulations of valacyclovir hydrochloride tablets
US20050051922A1 (en) * 2002-09-20 2005-03-10 Avinash Nangia Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
US20050070711A1 (en) * 2002-10-16 2005-03-31 Igor Lifshitz Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
US20050059684A1 (en) * 2002-10-16 2005-03-17 Ben-Zion Dolitzky Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
EP1633753A1 (en) * 2003-05-30 2006-03-15 EOS Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ti Caret A.S. Novel crystalline forms of valacyclovir hydrochloride
KR100871621B1 (ko) * 2003-06-02 2008-12-02 테바 파마슈티컬 인더스트리즈 리미티드 발라시클로비르 히드로클로라이드의 신규한 결정질 형태
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
DK3260117T3 (da) 2003-09-12 2019-07-01 Amgen Inc Hurtigt opløsende formulering, der omfatter cinacalcet-hcl
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
ES2246034T3 (es) * 2003-12-09 2006-02-01 Helm Ag Formulacion farmaceutica de valaciclovir.
US7344907B2 (en) * 2004-11-19 2008-03-18 International Business Machines Corporation Apparatus and methods for encapsulating microelectromechanical (MEM) devices on a wafer scale
KR101116747B1 (ko) 2004-12-06 2012-02-22 에스케이케미칼주식회사 안정성이 개선된 말레인산 암로디핀 약제 조성물
US9737488B2 (en) 2005-03-07 2017-08-22 Bayer Healthcare Llc Pharmaceutical composition for the treatment of cancer
ATE546451T1 (de) * 2005-05-25 2012-03-15 Lilly Co Eli Cyclopropancarbonsäureester von acyclovir
EP1746098A1 (en) * 2005-07-21 2007-01-24 SOLMAG S.p.A. Valacyclovir polymorphs and a process for the preparation thereof
WO2007090595A1 (en) * 2006-02-06 2007-08-16 Fidia Pharmaceutici S.P.A. Solid formulations of valacyclovir hydrochloride
EP2023899A1 (en) * 2006-05-10 2009-02-18 Evonik Degussa GmbH Use of roll compacted pyrogenically produced silicon dioxide in pharmaceutical compositions
RU2446800C2 (ru) * 2006-05-31 2012-04-10 Вертекс Фармасьютикалз Инкорпорейтед Препаративные формы с контролируемым высвобождением
US20090291136A1 (en) * 2006-07-11 2009-11-26 Lek Pharmaceuticals D.D. Multiple Unit Tablets
US20080167325A1 (en) * 2006-12-27 2008-07-10 Bs Praveen Kumar Valacyclovir compositions
US20090076039A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched valacyclovir
ITRM20080027A1 (it) * 2008-01-18 2009-07-19 Maria Balestrieri Uso di aciclovir per il trattamento delle condilomatosi.
US20100124560A1 (en) * 2008-11-14 2010-05-20 Mcneil Ab Multi portion intra-oral dosage form and use thereof
KR101665395B1 (ko) * 2009-03-13 2016-10-12 토야마 케미칼 컴퍼니 리미티드 6-플루오로-3-히드록시-2-피라진카르복사미드 함유 정제 및 조립분말
CH703348A1 (de) * 2010-06-29 2011-12-30 Mepha Gmbh Zusammensetzungen mit hohem Wirkstoffanteil an pharmazeutisch aktiven Substanzen.
GB2515486A (en) * 2013-06-24 2014-12-31 Kraft Foods R & D Inc Soluble Beverage Ingredients
KR101497508B1 (ko) * 2013-12-20 2015-03-03 한국유나이티드제약 주식회사 펠라고니움 시도이데스 추출물 및 규산 화합물을 포함하는 고형 제제 및 이의 제조 방법
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
WO2020049536A1 (en) * 2018-09-07 2020-03-12 Jubilant Generics Limited Pharmaceutical compositions of valacyclovir or its pharmaceutically acceptable salts thereof
CN110279667B (zh) * 2019-07-30 2023-02-10 珠海润都制药股份有限公司 一种盐酸伐昔洛韦片及其制备方法
CN115666516A (zh) * 2020-06-01 2023-01-31 希尔帕医疗保健有限公司 包括卡培他滨的快速分散药物组合物
WO2022119270A1 (ko) * 2020-12-01 2022-06-09 주식회사 엘지화학 1-(3-시아노-1-아이소프로필-인돌-5-일)피라졸-4-카르복실산을 포함하는 경구용 제제, 및 그의 제조방법
CA3266275A1 (en) * 2022-08-31 2024-03-07 Astrazeneca Ab PHARMACEUTICAL FORMULATION

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1259924A (en) * 1985-03-25 1989-09-26 Wallace E. Becker Pharmaceutical tableting method
AP55A (en) * 1987-08-15 1989-09-26 The Wellcome Foundation Ltd Therapeutic Acyclic Nucleosides
DE68903605T2 (de) * 1988-05-04 1993-04-01 Smith Kline French Lab Kautablette.
DE69207656T2 (de) * 1991-01-30 1996-10-17 The Wellcome Foundation Ltd., London Wasserlösliche tabletten
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
GB9317146D0 (en) * 1993-08-18 1993-10-06 Wellcome Found Therapeutic combinations
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet

Also Published As

Publication number Publication date
CY2182B1 (en) 2002-08-23
EP0806943A1 (en) 1997-11-19
GR3033677T3 (en) 2000-10-31
MY126346A (en) 2006-09-29
AU4453496A (en) 1996-08-07
CZ296514B6 (cs) 2006-03-15
WO1996022082A1 (en) 1996-07-25
NZ298846A (en) 1998-06-26
HU226131B1 (en) 2008-05-28
JP3350055B2 (ja) 2002-11-25
MX9705459A (es) 1997-10-31
TR199700657T1 (xx) 1998-02-21
HK1002851A1 (en) 1998-09-25
BG63187B1 (bg) 2001-06-29
OA10500A (en) 2002-04-10
EA000276B1 (ru) 1999-02-25
BG101831A (en) 1998-04-30
NO973327L (no) 1997-09-16
FI119722B (fi) 2009-02-27
AU710823B2 (en) 1999-09-30
KR100412298B1 (ko) 2004-04-21
JPH10512564A (ja) 1998-12-02
EP0806943B1 (en) 2000-03-15
IL116830A (en) 2000-02-29
GEP20022752B (en) 2002-08-26
NO311488B1 (no) 2001-12-03
KR19980701524A (ko) 1998-05-15
CZ229297A3 (cs) 1998-02-18
FI973062A0 (fi) 1997-07-18
SK282030B6 (sk) 2001-10-08
IL116830A0 (en) 1996-05-14
CN1313081C (zh) 2007-05-02
UY25774A1 (es) 2000-10-31
US5879706A (en) 1999-03-09
CA2210891A1 (en) 1996-07-25
CN1131026C (zh) 2003-12-17
ES2145425T3 (es) 2000-07-01
DE69607146T2 (de) 2000-09-21
PL185307B1 (pl) 2003-04-30
EA199700123A1 (ru) 1997-12-30
ZA96448B (en) 1996-08-07
GB9501127D0 (en) 1995-03-08
RO118175B1 (ro) 2003-03-28
NO973327D0 (no) 1997-07-18
UY25778A1 (es) 2000-08-21
AP666A (en) 1998-08-24
HUP9801872A3 (en) 2001-02-28
HUP9801872A2 (hu) 1999-10-28
EE03336B1 (et) 2001-02-15
CN1494898A (zh) 2004-05-12
IN181318B (OSRAM) 1998-05-09
DK0806943T3 (da) 2000-07-24
PL321361A1 (en) 1997-12-08
PT806943E (pt) 2000-08-31
ATE190483T1 (de) 2000-04-15
AP9701057A0 (en) 1997-10-31
DE69607146D1 (de) 2000-04-20
UA68325C2 (en) 2004-08-16
SK96497A3 (en) 1998-01-14
CN1179100A (zh) 1998-04-15
CA2210891C (en) 2009-05-19
FI973062L (fi) 1997-09-18

Similar Documents

Publication Publication Date Title
BR9606769A (pt) Tablete e processos para tratamento de uma infecção de vírus do herpes em um humano e para preparação do tablete
IL126924A0 (en) Antimicrobial treatment for herpes simplex virus and other infectious diseases
ITMI951160A0 (it) Chiodo endomidollare bloccato adatto in particolare per le fratture del femore
EP0831873A4 (en) COMBINATORY THERAPY FOR THE TREATMENT OF HIV AND OTHER VIRAL INFECTIONS
FI963696A7 (fi) Geeli ihosairauksien hoitoon ja ihon desinfiointiin
AU7230196A (en) Pskh-1 ribozymes and uses in disease treatment
FI962559A7 (fi) Hormonaaliseen raskauden ehkäisyyn ja/tai aknen hoitoon tarkoitettu lääke ja menetelmä
EE03774B1 (et) 5-O-desosaminüül-6-O-metüülerütronoliid A derivaadid, nende valmistamismeetod ja kasutamine bioaktiivsete produktide valmistamiseks
HUP0002744A3 (en) Rapidly releasing and taste-masking pharmaceutical dosage form
FI944600A0 (fi) Imidatsol-4-yylipiperidiinijohdannaisia, niiden valmistus ja niiden käyttö terapiassa
ZA936592B (en) Nutrition for persons infected with human immunodeficiency virus
IL102092A0 (en) Vaccine and treatment method for human immunodeficiency virus
HUP9900584A3 (en) Novel benzoyl guanidine derivatives, process for their preparation and their use in the preparation of medicines
FI955426A7 (fi) Pintakäsittelytuotteet ja menetelmät niiden valmistamiseksi
EE04371B1 (et) Fenüülamidiini derivaadid, meetodid nende valmistamiseks ja nende kasutamine arstimitena
BR9607599A (pt) Ifn-con qumicamente modificado composição farmacêutica preparação processo de tratamento de um paciente possuindo uma condição tratável com ifn-con e processo de liberação de um interferon
FI941911L (fi) Kondensoidut kinolyylidihydropyridiinit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
GB8926595D0 (en) Pharmaceutical compositions for use in the treatment herpes simplex virus infections
BR9607169A (pt) Uso de meletonina e formulação farmacêutica para uso no tratamento de um viciado em drogas múltiplas
GB9015051D0 (en) Pharmaceutical treatment
BR9601193A (pt) Vacina de múltiplos componentes e processos para preparar e administrar a vacina
AU3909389A (en) Il-1alpha derivatives and medicament for treating thrombocytopenia
DK0726250T3 (da) Substituerede benzensulfonylurinstoffer og -thiourinstoffer, fremgangsmåder til deres fremstilling og deres anvendelse til
FI950728L (fi) 15-deoksispergualiinianalogit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkinnässä
FI941913A7 (fi) Kinolyylidihydropyridiiniestereitä, menetelmiä niiden valmistamiseksi ja niiden käyttö lääkeaineissa

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
HJEG Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law
FF Decision: intention to grant
FG9A Patent or certificate of addition granted
B17A Notification of administrative nullity (patentee has 60 days time to reply to this notification)

Free format text: NATURE'S PLUS FARMACEUTICAL LTDA.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE AS 16A, 17A, 18A, 19A E 20A ANUIDADES.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.